CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Peter L. Carlen

OPENALEX: A5044113968↗ORCID: 0000-0002-3339-8102↗

Affiliations

Organizations

Toronto Western Hospitalauthorship · CA Western Research Instituteauthorship · US

Public evidence

2 connected articles

Canadian real-world evidence: observational 24-week outcomes for health care practitioner authorized cannabis.2026 · Europe PMC Cannabidiol Exerts Anticonvulsant Effects Alone and in Combination with Δ<sup>9</sup>-THC through the 5-HT1A Receptor in the Neocortex of Mice.2024 · Europe PMC

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Peter L. Carlen - Medical Cannabis Research Engine